
Ovid Therapeutics Inc.
Ovid Therapeutics Inc.(OVID)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
ovid · 股价预测 · 14 位分析师(近3月)· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Buy
14 位分析师
共识
评级分布
12 个月目标价
High
$7.00
Consensus
$5.50
+126.8% upside
Low
$4.00
Median: $5.5 · Last Close: $2.42
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$5.50
126.8% upside
High Target
$7
188.7%
Low Target
$4
64.9%
Current Price
$2.42
as of today
Based on analyst price targets, the OVID stock price prediction for the next 12 months ranges from $4 to $7. The consensus OVID price forecast of $5.50 implies 126.8% upside from the current price of $2.42.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.35 | ↓ 3.29% |
1-day model range: $2.33–$2.36. Peak: $2.36 (-3.29%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | +45.1% |
| 2028 | $4 | +81.1% |
| 2029 | $5 | +105.8% |
| 2030 | $5 | +121.3% |
| 2031 | — | +130.4% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · OVID · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-15 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-26 | BTIG | Maintains | Buy→Buy |
| 2026-03-20 | Wedbush | Maintains | Outperform→Outperform |
| 2025-12-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-24 | BTIG | Maintains | Buy→Buy |
| 2025-03-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-12 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Ovid Therapeutics Inc. (OVID) stock. Of the recent 39 rating actions, 1 were upgrades and 3 were downgrades. 14 analysts currently cover OVID.
分析师推荐趋势
OVID analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 2 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$0M
↓ 41.6% YoY
Revenue Next Year
$0M
↑ 39.5% YoY
EPS This Year
$-0.48
EPS Next Year
$-0.53
↑ 10.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast OVID EPS of $-0.48 for the current fiscal year, based on estimates from 8 analysts. The OVID revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
OVID 股价预测由两类独立数据源支撑:来自 14 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。OVID 的共识目标价为 $5.50(+126.8% 上行空间),分析师共识为 Buy。
OVID 的短期预测(明日)为 $2.35(-3.29%)。 OVID 对 2027 年的股价预测均值为 $4。 OVID 对 2030 年的预测区间为 $5–$6。
Ovid Therapeutics Inc. 在 NASDAQ 上市,代码 OVID。OVID 在 2027 年的整体展望偏积极,在覆盖分析师中约 79% 对应 Buy 共识。
常见问题
OVID 预测 · 8 个问题根据 14 位华尔街分析师,OVID 的 12 个月平均目标价为 $5.50,最高 $7.00、最低 $4.00。若有图表,中位目标价可在上方查看。相对当前价 $2.42,隐含约 +126.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.